AN2 Therapeutics, Inc. (ANTX)

AN2 Therapeutics Analyst Ratings

• Total Analysts: 4
• Consensus Rating: Buy
• Price Target: $2.50
• Upside: +150.00%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Roy Buchanan JMP Securities	JMP Securities	Buy Maintains $6 → $3	Buy	Maintains	$6 → $3	+200.00%	Aug 9, 2024
Joseph Schwartz Leerink Partners	Leerink Partners	Hold → Buy Upgrades n/a	Hold → Buy	Upgrades	n/a	n/a	Jul 3, 2024
Liisa Bayko Evercore ISI Group	Evercore ISI Group	Hold Maintains $7 → $2	Hold	Maintains	$7 → $2	+100.00%	May 16, 2024
Roy Buchanan JMP Securities	JMP Securities	Hold → Buy Upgrades $6	Hold → Buy	Upgrades	$6	+500.00%	Apr 2, 2024
Jeff Jones Oppenheimer	Oppenheimer	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Apr 1, 2024
Joseph Schwartz Leerink Partners	Leerink Partners	Buy → Hold Downgrades $23 → $7	Buy → Hold	Downgrades	$23 → $7	+600.00%	Feb 13, 2024
Liisa Bayko Evercore ISI Group	Evercore ISI Group	Buy → Hold Downgrades $25 → $7	Buy → Hold	Downgrades	$25 → $7	+600.00%	Feb 12, 2024
Jeff Jones Oppenheimer	Oppenheimer	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Feb 12, 2024
Roy Buchanan JMP Securities	JMP Securities	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Feb 12, 2024
Roy Buchanan JMP Securities	JMP Securities	Buy Initiates $30	Buy	Initiates	$30	+2,900.00%	Jan 4, 2024
Jeff Jones Oppenheimer	Oppenheimer	Buy Maintains $20 → $24	Buy	Maintains	$20 → $24	+2,300.00%	Mar 30, 2023
Joseph Schwartz SVB Leerink	SVB Leerink	Buy Maintains $27 → $25	Buy	Maintains	$27 → $25	+2,400.00%	Nov 14, 2022
Liisa Bayko Evercore ISI Group	Evercore ISI Group	Buy Initiates $25	Buy	Initiates	$25	+2,400.00%	Apr 19, 2022
Kevin DeGeeter Oppenheimer	Oppenheimer	Buy Initiates $22	Buy	Initiates	$22	+2,100.00%	Apr 19, 2022
Ritu Baral Cowen & Co.	Cowen & Co.	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Apr 19, 2022